MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on February 21, 2007; DOI: 10.1124/mol.106.033621


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.033621v1
71/5/1209    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niforatos, W.
Right arrow Articles by Chen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niforatos, W.
Right arrow Articles by Chen, J.


Received for publication December 20, 2006.
Revised February 15, 2007.
Accepted for publication February 15, 2007.

Activation of TRPA1 Channels by the Fatty Acid Amide Hydrolase Inhibitor URB597

Wende Niforatos 1, XuFeng Zhang 1, Marc R Lake 1, Karl A Walter 1, Torben Neelands 1, Thomas F Holzman 1, Victoria E Scott 1, Connie R Faltynek 1, Robert B Moreland 1, Jun Chen 2*

1 Abbott Laboratories 2 Abbott laboratories

* Address correspondence to: E-mail: jun.x.chen{at}abbott.com

Abstract

As a member of the transient receptor potential (TRP) ion channel superfamily, the ligand-gated ion channel TRPA1 has been implicated in nociceptive function and pain states. The endogenous ligands that activate TRPA1 remain unknown. However various agonists have been identified, including environmental irritants (e.g., acrolein) and ingredients of pungent natural products (e.g., allyl isothiocyanate or ITC, cinnamaldehyde, allicin and gingerol). In general, these agents are either highly reactive, nonselective, or not potent or efficacious, significantly limiting their utilities in the study of TRPA1 channel properties and biological functions. In a search for novel TRPA1 agonists, we identified 3'-carbamoylbiphenyl-3-yl cyclohexylcarbamate (URB597), a potent and systemically active inhibitor of fatty acid amide hydrolase (FAAH). This enzyme is responsible for anandamide degradation therefore has been pursued as an anti-nociceptive and anti-epleptic drug target. Using Ca2+ influx assays and patch-clamp techniques, we demonstrated that URB597 could activate heterologously expressed human and rat TRPA1 channels, while two other FAAH inhibitors (i.e., URB532 and Compound 7) had no effect. When applied to inside-out membrane patches expressing rat TRPA1, URB597 elicited single-channel activities with a unitary conductance of 40 pS. Furthermore, URB597 activated TRPA1 channels endogenously expressed in a population of rat dorsal root ganglion neurons that also responded to ITC. In contrast to its effect on TRPA1, URB597 inhibited TRPM8 and had no effects on TRPV1 or TRPV4. Thus we conclude that URB597 is a novel agonist of TRPA1 and likely activates the channel through a direct gating mechanism.


Key words: Ion channel regulation, Func. analysis receptor/ion channel mutants, Single channel kinetics


This article has been cited by other articles:


Home page
J. Neurosci.Home page
J. Chen, X.-F. Zhang, M. E. Kort, J. R. Huth, C. Sun, L. J. Miesbauer, S. C. Cassar, T. Neelands, V. E. Scott, R. B. Moreland, et al.
Molecular Determinants of Species-Specific Activation or Blockade of TRPA1 Channels
J. Neurosci., May 7, 2008; 28(19): 5063 - 5071.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Maher, H. Ao, T. Banke, N. Nasser, N.-T. Wu, J. G. Breitenbucher, S. R. Chaplan, and A. D. Wickenden
Activation of TRPA1 by Farnesyl Thiosalicylic Acid
Mol. Pharmacol., April 1, 2008; 73(4): 1225 - 1234.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics